ArticleInternational dental journal2026
Periodontal Disease Burden in China and G20 Nations: Insights From the Global Burden of Disease 2023 Study.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Burden trends and disparities of metabolic risk-attributable peripheral arterial disease in China (1990-2035): a comparative analysis with G20 countries.International journal of public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThis study aimed to compare the periodontal disease burden between China and G20 countries from 1990 to 2023, to identify temporal trends using joinpoint regression, to quantify the respective contributions of population growth, aging, and epidemiological changes through demographic decomposition analysis, and to forecast the future burden to 2033 using autoregressive integrated moving average (ARIMA) models.
methodsLeveraging the most recent Global Burden of Disease Study (GBD) 2023 data, we analysed incidence and disability-adjusted life years (DALY). Joinpoint regression characterized trends. Demographic decomposition analysis quantified contributions from population growth, aging, and epidemiological changes. Future burden was projected using ARIMA models.
resultsThe burden varied substantially across G20 nations. In 2023, China showed a moderately high burden with age-standardized incidence rate of 950.20 per 100,000 and DALY rate of 68.5 per 100,000, with marked male predominance (ratio ∼1.2:1) and peak in 45-59 years. Joinpoint analysis revealed an overall slight decline in China's incidence (AAPC = -0.13) but a notable increase during 2010-2014 (APC = 4.79). Decomposition analysis identified aging as the main driver of increased incident cases in China (contributing 67.12% of 7.65 million increase), whereas population growth dominated in G20 countries (+120.87% contribution). ARIMA projections suggest China's DALY rates may stabilize around 64-65 per 100,000 by 2033, while G20 rates remain persistently higher at approximately 78 per 100,000.
conclusionPeriodontal disease burden in China is primarily driven by population aging, while population growth is the main factor in G20 countries. Tailored public health strategies are essential for each context. CLINICAL RELEVANCE: From a public health perspective, these findings highlight need for targeted population-level strategies: In China, resource allocation should prioritize high-risk groups (e.g., middle-aged males and the elderly). In G20 countries, health planning should address persistent high DALY burden through integrated non-communicable disease prevention programs targeting shared risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.